Yang, Soo Jin <br/><br/>
Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes.  [electronic resource] 

 -  The Journal of nutritional biochemistry  Jan 2014 
 - 66-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-4847 
<br/><br/><label>Standard No.: </label>10.1016/j.jnutbio.2013.09.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>DNA, Mitochondrial--genetics<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Diet, High-Fat<br/>Disease Models, Animal<br/>Energy Metabolism<br/>Glucose--metabolism<br/>Glucose Tolerance Test<br/>Insulin Resistance<br/>Liver--drug effects<br/>Male<br/>Mitochondrial Turnover--drug effects<br/>NAD--metabolism<br/>Niacinamide--pharmacology<br/>Nicotinamide Phosphoribosyltransferase--metabolism<br/>Obesity--drug therapy<br/>Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha<br/>Rats<br/>Rats, Inbred OLETF<br/>Signal Transduction<br/>Sirtuin 1--genetics<br/>Sirtuins--genetics<br/>Transcription Factors--genetics